A P Gjesing1, C T Ekstrøm, H Eiberg, S A Urhammer, J J Holst, O Pedersen, T Hansen. 1. Novo Nordisk Foundation Center for Basic Metabolic Research, Section of Metabolic Genetics, University of Copenhagen, Universitetsparken 1, DK-2100 Copenhagen, Denmark. anette.gjesing@sund.ku.dk
Abstract
AIMS/HYPOTHESIS: Heritability estimates have shown a varying degree of genetic contribution to traits related to type 2 diabetes. Therefore, the objective of this study was to investigate the familiality of fasting and stimulated measures of plasma glucose, serum insulin, serum C-peptide, plasma glucose-dependent insulinotropic polypeptide (GIP) and plasma glucagon-like peptide-1 (GLP-1) among non-diabetic relatives of Danish type 2 diabetic patients. METHODS: Sixty-one families comprising 193 non-diabetic offspring, 29 non-diabetic spouses, 72 non-diabetic relatives (parent, sibling, etc.) and two non-related relatives underwent a 4 h 75 g OGTT with measurements of plasma glucose, serum insulin, serum C-peptide, plasma GIP and plasma GLP-1 levels at 18 time points. Insulin secretion rates (ISR) and beta cell responses to glucose, GIP and GLP-1 were calculated. Familiality was estimated based on OGTT-derived measures. RESULTS: A high level of familiality was observed during the OGTT for plasma levels of GIP and GLP-1, with peak familiality values of 74 ± 16% and 65 ± 15%, respectively (h (2) ± SE). Familiality values were lower for plasma glucose, serum insulin and serum C-peptide during the OGTT (range 8-48%, 14-44% and 15-61%, respectively). ISR presented the highest familiality value at fasting reaching 59 ± 16%. Beta cell responsiveness to glucose, GLP-1 and GIP also revealed a strong genetic influence, with peak familiality estimates of 62 ± 13%, 76 ± 15% and 70 ± 14%, respectively. CONCLUSIONS/ INTERPRETATION: Our results suggest that circulating levels of GIP and GLP-1 as well as beta cell response to these incretins are highly familial compared with more commonly investigated measures of glucose homeostasis such as fasting and stimulated plasma glucose, serum insulin and serum C-peptide.
AIMS/HYPOTHESIS: Heritability estimates have shown a varying degree of genetic contribution to traits related to type 2 diabetes. Therefore, the objective of this study was to investigate the familiality of fasting and stimulated measures of plasma glucose, serum insulin, serum C-peptide, plasma glucose-dependent insulinotropic polypeptide (GIP) and plasma glucagon-like peptide-1 (GLP-1) among non-diabetic relatives of Danish type 2 diabeticpatients. METHODS: Sixty-one families comprising 193 non-diabetic offspring, 29 non-diabetic spouses, 72 non-diabetic relatives (parent, sibling, etc.) and two non-related relatives underwent a 4 h 75 g OGTT with measurements of plasma glucose, serum insulin, serum C-peptide, plasma GIP and plasma GLP-1 levels at 18 time points. Insulin secretion rates (ISR) and beta cell responses to glucose, GIP and GLP-1 were calculated. Familiality was estimated based on OGTT-derived measures. RESULTS: A high level of familiality was observed during the OGTT for plasma levels of GIP and GLP-1, with peak familiality values of 74 ± 16% and 65 ± 15%, respectively (h (2) ± SE). Familiality values were lower for plasma glucose, serum insulin and serum C-peptide during the OGTT (range 8-48%, 14-44% and 15-61%, respectively). ISR presented the highest familiality value at fasting reaching 59 ± 16%. Beta cell responsiveness to glucose, GLP-1 and GIP also revealed a strong genetic influence, with peak familiality estimates of 62 ± 13%, 76 ± 15% and 70 ± 14%, respectively. CONCLUSIONS/ INTERPRETATION: Our results suggest that circulating levels of GIP and GLP-1 as well as beta cell response to these incretins are highly familial compared with more commonly investigated measures of glucose homeostasis such as fasting and stimulated plasma glucose, serum insulin and serum C-peptide.
Authors: R M Watanabe; T Valle; E R Hauser; S Ghosh; J Eriksson; K Kohtamäki; C Ehnholm; J Tuomilehto; F S Collins; R N Bergman; M Boehnke Journal: Hum Hered Date: 1999-06 Impact factor: 0.444
Authors: P Almgren; M Lehtovirta; B Isomaa; L Sarelin; M R Taskinen; V Lyssenko; T Tuomi; L Groop Journal: Diabetologia Date: 2011-08-09 Impact factor: 10.122
Authors: Lisa L Morselli; Eric R Gamazon; Esra Tasali; Nancy J Cox; Eve Van Cauter; Lea K Davis Journal: Diabetes Date: 2017-10-30 Impact factor: 9.461
Authors: Adam Hulman; Rebecca K Simmons; Dorte Vistisen; Adam G Tabák; Jacqueline M Dekker; Marjan Alssema; Femke Rutters; Anitra D M Koopman; Thomas P J Solomon; John P Kirwan; Torben Hansen; Anna Jonsson; Anette Prior Gjesing; Hans Eiberg; Arne Astrup; Oluf Pedersen; Thorkild I A Sørensen; Daniel R Witte; Kristine Færch Journal: Endocrine Date: 2016-10-03 Impact factor: 3.633
Authors: Peter Almgren; Andreas Lindqvist; Ulrika Krus; Liisa Hakaste; Emilia Ottosson-Laakso; Olof Asplund; Emily Sonestedt; Rashmi B Prasad; Esa Laurila; Marju Orho-Melander; Olle Melander; Tiinamaija Tuomi; Jens Juul Holst; Peter M Nilsson; Nils Wierup; Leif Groop; Emma Ahlqvist Journal: JCI Insight Date: 2017-11-02
Authors: Stine B Thomsen; Anette P Gjesing; Camilla N Rathcke; Claus T Ekstrøm; Hans Eiberg; Torben Hansen; Oluf Pedersen; Henrik Vestergaard Journal: PLoS One Date: 2015-07-21 Impact factor: 3.240
Authors: Marie Neergaard Harder; Emil Vincent Rosenbaum Appel; Niels Grarup; Anette Prior Gjesing; Tarunveer S Ahluwalia; Torben Jørgensen; Cramer Christensen; Ivan Brandslund; Allan Linneberg; Thorkild I A Sørensen; Oluf Pedersen; Torben Hansen Journal: PLoS One Date: 2015-03-23 Impact factor: 3.240
Authors: Simona Ferjan; Mojca Jensterle; Tjasa Oblak; Irena Prodan Zitnik; Janja Marc; Katja Goricar; Vita Dolzan; Andrej Janez Journal: J Int Med Res Date: 2019-08-23 Impact factor: 1.671
Authors: Chia Lin Chang; James J Cai; Shang Yu Huang; Po Jen Cheng; Ho Yen Chueh; Sheau Yu Teddy Hsu Journal: PLoS One Date: 2014-09-15 Impact factor: 3.240